chrisvoncsefalvay/vaers-outcomes huggingface dataset:
16 year old patient received the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient received the vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient received the vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient received the vaccine) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was not aware if the patient was on any concomitant medication and there was no information about treatment medication. Additionally, reporter did not know if the patient experienced any symptom after receiving the vaccines. Reportedly, patient received the vaccines under the Moderna Clinical Trials and asking that if he could get a booster dose of the Pfizer Vaccine.
Pityriasis rosea; Rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PITYRIASIS ROSEA (Pityriasis rosea) and RASH (Rash) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included Herpes simplex (Improvement) on 10-Jan-2012. Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (JUNEL FE) from 01-Jan-2010 to an unknown date for Birth control.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced RASH (Rash). On 11-Feb-2021, the patient experienced PITYRIASIS ROSEA (Pityriasis rosea). At the time of the report, PITYRIASIS ROSEA (Pityriasis rosea) outcome was unknown and RASH (Rash) was resolving.            Steroid cream and Betamethasone propionate ointment are the treatment medication reported by reporter.  Patient experienced Full body rash. Began on chest/breast area, then spread to arms, torso, back, legs. Rash is almost completely gone, still some residual spots on chest   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow up received on 28APR2021, updated patient demographics, past medical history, concomitant medication use for JUNEL Fe, treatment medication and outcome for rash is recovering
Slept for 23 hours straight afterwards; Painful headache behind left eye; Extremely tired; This is a spontaneous report from a contactable consumer (patient). A 48-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ENG202) via an unspecified route of administration in left arm on 25Feb2021 at 16:00 (at the age of 48-years-old) as dose 1, single for covid-19 immunization. The patient medical history included psoriatic arthritis. Patient was known allergic to penicillin and sulfa drug. The patient previously took acetylsalicylic acid (Aspirin) and experienced allergy. Concomitant medication included apremilast (OTEZLA). The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 25Feb2021 at 16:00, patient experienced painful headache behind left eye for 20 minutes on scale of 8/10, pain subsided to 2/10 pain scale from 20 minutes to next 24 hours. Patient took ibuprofen (MANUFACTURER UNKNOWN) and acetaminophen (TYNENOL) for pain. After 24 hours pain subsided to 0/10. The patient was extremely tired and slept for 23 hours straight afterwards. The patient underwent lab tests and procedures which included pain assessment: 8/10 on 25Feb2021, 2/10 on 26Feb2021, and 0/10 on 27Feb2021. It was reported that the events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and treatment included ice pack, water, GATORAID, ibuprofen (MANUFACTURER UNKNOWN) and acetaminophen (TYNENOL). The clinical outcome of the events extremely tired and slept for 23 hours straight afterwards were recovered with lasting effects on an unspecified date in 2021 and headache was recovered on 27Feb2021.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : -PFIZER INC-2021386691 similar report from same reporter
Hives extending 4+ inches down and around the arm, redness and swelling that extended to shoulder and spine and to the distal phalanges.
Mild fever, feeling cold, tired, sore all over the body and the area of vaccine injection
Pt was seen in ER 4 1/2 hrs p/receiving 1st DTP/OPV/HIB; pt cried for 4-6 hrs, t100.6; unable to keep cold compress on leg as pt cried so much;
Patient received a flu shot at 12:10pm we spoke for several minutes before and after the shot. He then shopped the store and was getting ready to be rang out at the front registers when he felt faint and took a knew and fainted. Patient hit his right orbital on the floor. He regained consciousness immediately. During questioning he mentioned that he had not eaten at all that day which may have contributed to the fainting. He has had a variety of vaccines in the past without incident. He was checked out by the EMTs and they stated that his vitals where normal.
A few minutes after the vaccine I had a lot of heat and pain in my  left ear. My left ear is still painful after four weeks. I am scheduled to see an ENT doctor today. I had to go to the emergency room because I was throwing up starting two hours after the vaccine and I was in pain all over my body. I became extremely fatigued, and I could not stop throwing up. I was given Reglan, to stop the vomiting, and I am still taking it twice daily after four weeks. I was also given Benadryl which seemed to help. I tried to stop taking the nausea medicine after three weeks and the vomiting returned. I threw up eight times that day. I still have aches in my legs and ear pain every day after four weeks. My fatigue has improved a little.
A rash appeared on my lower left arm and has spread a bit to my upper arm.  Each day the rash is more widespread although there is no fever, no itching, no raised bumps.  I contacted my doctor who provides care management for lymphedema, and provided pictures of the rash.  He agrees it is not a cellulitis infection but can provide no further information and did not ask me to come for an appointment.
Feeling flu symptoms w/o fever, felt weak, heavy chest, swelling of right upper inner leg, some loss of taste, head pressure in sinus area and forehead, and shakiness. Rest and slept on Monday. Went to ER on Tuesday. Was diagnosed with vaccine reaction. Went home and slept again. Return to work on Wednesday. Symptoms are getting better except for the right upper inner leg which is still the same.
DIAGNOSED WITH SHINGLES 01/26/2009 PATIENT HAS ONLY RECEIVED ONE DOSE OF VARIVAX LISTED ABOVE
she is not having trouble breathing so much, but it hurts when she breathes; he can hear her breathe with difficulty when she speaks; like a bad flu; she's miserable.She feels worse now than with second dose; she has pains and aches all over; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (she is not having trouble breathing so much, but it hurts when she breathes), BREATH SOUNDS (he can hear her breathe with difficulty when she speaks), INFLUENZA LIKE ILLNESS (like a bad flu), FEELING ABNORMAL (she's miserable.She feels worse now than with second dose) and MYALGIA (she has pains and aches all over) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 077C21B and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (she is not having trouble breathing so much, but it hurts when she breathes), BREATH SOUNDS (he can hear her breathe with difficulty when she speaks), INFLUENZA LIKE ILLNESS (like a bad flu), FEELING ABNORMAL (she's miserable.She feels worse now than with second dose) and MYALGIA (she has pains and aches all over). At the time of the report, DYSPNOEA (she is not having trouble breathing so much, but it hurts when she breathes), BREATH SOUNDS (he can hear her breathe with difficulty when she speaks), INFLUENZA LIKE ILLNESS (like a bad flu), FEELING ABNORMAL (she's miserable.She feels worse now than with second dose) and MYALGIA (she has pains and aches all over) outcome was unknown.            The patient had no fever no difficulty breathing previous to the shots not and not diagnosed with COVID-19. The patient was pretty healthy, never diagnosed with heart problems or breathing problems. No concomitant medications were reported. No treatment information was provided.
SUSPECTED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 35 year old male of unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1808979 expiry: unknown) dose was not reported, 1 total administered on 09-APR-2021 for covid-19 prophylaxis. Age at time of vaccination 34 years old.  It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient additionally received second dose of non-company suspect vaccine included: Pfizer Biontech (tozinameran) (dose number in series 2) (form of admin, route of admin were not reported, batch number: FF2587 expiry: UNKNOWN) dose was not reported, administered on 09-SEP-2021 for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination with second dose of non-company suspect vaccine Pfizer Biontech (dose number in series 2).  The patient additionally received third dose of Pfizer Biontech (tozinameran) (dose number in series 3) (form of admin, route of admin were not reported, batch number: GJ3277 expiry: UNKNOWN) dose was not reported, administered on 13-OCT-2022 for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (dose number in series 3). Concomitant medications included guaifenesin (Mucinex) and  pseudoephedrine hydrochloride (Sudafed). On an unspecified date in 2023, the patient experienced covid-19 infection (suspected covid-19 infection) (dose number in series 3).  The patient started taking treatment with unspecified suspect drug (form of admin, route of admin, batch number and expiry date were not reported) dose and frequency were not reported from 01-MAR-2023 to 05-MAR-2023 for treatment of covid-19. On 10-MAR-2023, after treatment with unspecified drug the patient experienced rebound covid-19 infection, after what he felt like a complete recovery. Symptoms were mild (runny nose, congestion, sneezing, headache) (dose number in series 3). The action taken with covid-19 vaccine ad26.cov2.s, tozinameran, and tozinameran was not applicable. The patient was recovering from suspected covid-19 infection, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.
nausea, vomiting, febrile, pain, swelling at injection site.  limited ROM at site,  pain
Patient developed all symptoms of Hepatitis A, beginning on Feb. 11,2018, 11 days after receiving the vaccine. She had stomach pain, gray stool, jaundice, dark urine and extreme tiredness.
Patient complained of aches and sweats x 3 or 4 over past month since flu vaccine.
Caller is a consumer asking if there is ingredient in the vaccine that can cause hair loss.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "Caller is a consumer asking if there is ingredient in the vaccine that can cause hair loss.".  Additional information: Caller was a consumer asking if there was an ingredient in the vaccine that can cause hair loss. Caller stated that she was calling about hair loss related to the Covid Vaccines. Stated that she does not know what was in it to cause hair loss. Asked if there was an ingredient in the vaccine that was known that could cause hair loss. Caller stated that she had the Pfizer Covid Vaccines, everyone having this problem from the Covid Vaccines. They don't want to lose their hair anymore.  Caller stated that it was a research study for her, not an official one, a self-reporting one. Stated that it all seems to go back to the vaccine. Caller declined to complete safety report, stated that she needed more information to see if she was on the right track. Caller mentioned that she was a healthcare professional and that she was a licensed counselor and a professor of mental health. Caller was not a doctor, pharmacist, or nurse. Declined to provide further contact information. Stated that the phone number she provided was the best contact. Disconnected from the call due to technical issues. The transfer was not completed.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
EPILEPSY, UNSPECIFIED 5/2/2023 SEIZURES, GENERALIZED, UNSPECIFIED TYPE
Pt states that her arm is painful, swollen, and red at injection site. She presented to me at the pharmacy on 4/2. I looked at injection site and did not a small amount of redness and swelling but nothing that seemed excessive. I advised that some injection site redness and swelling are normal but advised her I could not provide any diagnostic services and  to seek medical treatment with her PCP or urgent care.
Things smell abnormal, food smells like feces and nothing smells the way it should; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the arm left on 19Feb2021 at 08:00 at the age of 20-years-old as a single dose for COVID-19 immunisation. Medical history included generalized anxiety disorder (GAD), seasonal allergies, and COVID-19 in early December. Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included MONTELUKAST, ESCITALOPRAM, and oral birth control, all were taken for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the arm left on 29Jan2021 at 10:00 at the age of 19-years-old as a single dose for COVID-19 immunisation. On 19Feb2021, after the patient received Pfizer vaccine, the patient experienced things smell abnormal, food smells like feces, nothing smells the way it should, this was ongoing at the time of reporting. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event things smell abnormal, food smells like feces, nothing smells the way it should was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
strong ringing, thought was having high blood pressure.; haven't been able to sleep.; ears bordering; This case was reported by a consumer and described the occurrence of ringing in ears in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 21st October 2022, the patient received Shingles vaccine. In October 2022, several days after receiving Shingles vaccine, the patient experienced ear discomfort. On 30th October 2022, the patient experienced ringing in ears and sleeplessness. On an unknown date, the outcome of the ringing in ears, ear discomfort and sleeplessness were not recovered/not resolved.   It was unknown if the reporter considered the ringing in ears, ear discomfort and sleeplessness to be related to Shingles vaccine.     Additional Information: GSK receipt date: 08-Nov-2022 Reporter's comment:  The patient received the Shingle vaccine. After couple of days, the patient felt ears bordering. On Sunday, the patient ears were ringing so strong that patient thought having a high blood pressure. The patient's ears did not stop ringing up to the point so was unable to sleep.  After 9 days, the patient experienced ringing in ears and sleeplessness. The patient did not know what else to do and was asking for advice.
Within the first 10 minutes of vaccination, I started to get blurry vision and feel faint. A sensation came over my entire body and I couldn?t feel or control my body. I experienced tetany and lost control of my muscles in my arms, hands, and legs. A positive Trousseau sign was visible in both of my hands. All of these symptoms lasted about 15-20 minutes.
Noticed both of her eyes felt "sandy" like there was something in them and then a few hours they became red and very sore. In the morning the right one was much better but the left was still red and sore.
After administration of vaccines, child was noted to be pale and cyanotic. Cyanosis lasted about 1 1/2 min. and after, pallor persisted in face and upper extremities. Heart rate 144 - EMS called.
Pt recvd series of 3 hep B vax on 0,1,6 mo schedule & later 16JAN91 exp inject site react w/inflammation, swelling, chills, inc pain, diarrhea, cramping, T-100 & aching shoulder w/decreased mobility.
shingles; Pain; This is a spontaneous report from a contactable consumer (patient husband). A 70-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9261) via unspecified route on arm single dose for COVID-19 immunization on 21Jan2021, about 15:00, at 70-year-old. Medical history included: diagnosed allergies, compromised immune status, endocrine abnormalities, genetic / chromosomal abnormalities, respiratory illness, diabetes, obesity. The patient had a whole list of concomitant product medications (unspecified). The patient came down with shingles four and a half hours after the vaccine (21Jan2021, about 19:00 - 19:30), emergency room visited. They noticed a rash on her back which got worse, so she was taken to the hospital on 26Jan2021 and was diagnosed with shingles. She's still in the hospital but has gotten better. She was currently hospitalized for the shingles and related pain on 26Jan2021 that was more than she could handle. The patient had a few blood tests; urinalysis; a lot of sugar testing; and negative on the COVID test prior to them admitting her to the hospital. Action taken for BNT162B2 was not applicable. Outcome of the events was not resolved.
Event occurred after 2nd dose. Patient was diagnosed with COVID Remdesivir Discharged
I had my vaccination on 11/17/2022. I had a routine wellness examination on 01/23/2023. I was diagnosed with Lichen sclerosus on 01/30/2023. I was prescribed two different steroids. I do have a follow up scheduled for 03/06/2023.
Received expired vaccine on 05Jan2022; 3 patients who received the vaccine from same vial/ vaccine was opened on 04JAN2022 and administered on 05JAN2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine on 05Jan2022) and PRODUCT ADMINISTRATION ERROR (3 patients who received the vaccine from same vial/ vaccine was opened on 04JAN2022 and administered on 05JAN2022) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 05-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine on 05Jan2022) and PRODUCT ADMINISTRATION ERROR (3 patients who received the vaccine from same vial/ vaccine was opened on 04JAN2022 and administered on 05JAN2022). On 05-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine on 05Jan2022) and PRODUCT ADMINISTRATION ERROR (3 patients who received the vaccine from same vial/ vaccine was opened on 04JAN2022 and administered on 05JAN2022) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vaccine was opened at 8:17 AM on 04Jan2022 and needed to be discarded at 8:17 PM 04Jan2022. However, the same vial was used to administer the vaccine to 3 patients on 05Jan2022.  No adverse event reported to the facility. Treatment medications were not provided by the reporter.
The first two days or so, I had pain in my shoulder at the injection site. At the same time, I started feeling nauseous that week and that Thursday, the 25th, I got so nauseous I couldn't keep anything down - could not eat or drink or work. I called my Dr and they prescribed me some anti-nausea medicine. That helped with the symptoms. My symptoms have improved but they are still there - I am still nauseous and I am still taking medicines.  First pregnancy; My estimated date of delivery is November 18th or so.
Syncope immediately following the vaccination.  Irregular blood pressure recorded while sitting which improved once lying down